MS patients have increased levels of the citrullinated form of myelin basic protein (Wood et al., 1996; Moscarello et al., 2007), and both PAD2 and PAD4 are overexpressed in the brains of MS patients (Wood et al., 2008). This evidence concerns the gene PADI2 and myeloid sarcoma.